BioSpace News Archive

Business

Veeva to Release Fiscal 2022 Fourth Quarter and Full Year Results on March 2, 2022

Veeva Systems (NYSE: VEEV) will announce financial results for its fourth quarter and full fiscal year, which ended January 31, 2022 , after market close on March 2, 2022.

February 1, 2022

·

1 min read

Business

Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2021.

February 1, 2022

·

38 min read

Deals

MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

MEI Pharma, Inc. today announced the grant of inducement stock options for an aggregate of 588,000 shares of the company’s common stock to seven new employees.

February 1, 2022

·

4 min read

Biotech Bay

Personalis to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 15, 2022 at 2:00 p.m. Eastern Time.

February 1, 2022

·

1 min read

Treace to Announce Latest ALIGN3D™ Data at the 2022 ACFAS Scientific Conference

Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), today announced the upcoming podium presentation of the latest interim analysis from the ALIGN3D™ clinical study at the 2022 American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference.

February 1, 2022

·

3 min read

Pharm Country

BD Board of Directors Approves embecta Spinoff and Declares Distribution of embecta Stock

BD (Becton, Dickinson and Company) today announced its board of directors has approved the planned spinoff of its diabetes care business, which will be known as Embecta Corp.

February 1, 2022

·

8 min read

Deals

Gilead Sciences Announces 2.8 Percent Increase in First Quarter 2022 Dividend

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.8% in the company’s quarterly cash dividend, beginning in the first quarter of 2022.

February 1, 2022

·

1 min read

Business

PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the fourth quarter and full year ended January 2, 2022.

February 1, 2022

·

37 min read

Biotech Bay

Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced plans to participate in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

February 1, 2022

·

1 min read

Business

Transcat Reports Record Third Quarter EBITDA on Service Revenue Growth of 22% and Strong Gross Margin Expansion

Transcat, Inc. today reported financial results for its third quarter and nine-month period ended December 25, 2021 (the “third quarter”) of fiscal year 2022, which ends March 26, 2022.

February 1, 2022

·

20 min read